$ISIS IONIS PHARMACEUTICALS INC Insider Trading Week 42/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IONIS PHARMACEUTICALS INC in week 42/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 10.29 | 12,250 | 126,053 | 0 | |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 65.00 | 12,250 | 796,250 | 15,041 | 27.3 K to 15 K (-44.89 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 10.29 | 12,250 | 126,053 | 27,291 | 15 K to 27.3 K (+81.44 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Option Exercise | M | 39.87 | 8,333 | 332,237 | 74,167 | |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Option Exercise | M | 14.69 | 7,785 | 114,362 | 0 | |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Sell | S | 65.00 | 8,333 | 541,645 | 25,741 | 34.1 K to 25.7 K (-24.46 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | M | 39.87 | 8,333 | 332,237 | 34,074 | 25.7 K to 34.1 K (+32.37 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Sell | S | 65.00 | 7,785 | 506,025 | 25,741 | 33.5 K to 25.7 K (-23.22 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | M | 14.69 | 7,785 | 114,362 | 33,526 | 25.7 K to 33.5 K (+30.24 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 904 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 15,000 | 220,350 | 66,642 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 59.46 | 1,500 | 89,190 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 59.46 | 15,000 | 891,900 | 38,014 | 53 K to 38 K (-28.29 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 15,000 | 220,350 | 53,014 | 38 K to 53 K (+39.46 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 7.25 | 7,035 | 51,004 | 0 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 10.29 | 426 | 4,384 | 0 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 60.00 | 7,035 | 422,100 | 12,351 | 19.4 K to 12.4 K (-36.29 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 7.25 | 7,035 | 51,004 | 19,386 | 12.4 K to 19.4 K (+56.96 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 60.00 | 426 | 25,560 | 12,351 | 12.8 K to 12.4 K (-3.33 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 10.29 | 426 | 4,384 | 12,777 | 12.4 K to 12.8 K (+3.45 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 60.00 | 807 | 48,420 | 12,351 | 13.2 K to 12.4 K (-6.13 %) |